Toggle Side Panel
RaqabaIQ
  • Home
  • Features
  • About
  • Contact
More options
    Sign in
    • Features
    • About
    • Contact
    • Log In
    Close search

    Country: Sweden

    IRLABa – IRLAB Therapeutics AB

    IRLAB Therapeutics AB is Shariah Compliant. It passes 3/5 Shariah standards we screen against.

    XBRANE – Xbrane Biopharma AB

    Xbrane Biopharma AB is Shariah Compliant. It passes 5/5 Shariah standards we screen against.

    STZEb – Starbreeze AB

    Starbreeze AB is Shariah Compliant. It passes 3/5 Shariah standards we screen against.

    PIONb – PION Group AB

    PION Group AB is Shariah Compliant. It passes 3/5 Shariah standards we screen against.

    PREC – Precise Biometrics AB

    Precise Biometrics AB is Shariah Compliant. It passes 5/5 Shariah standards we screen against.

    IMMNOV – Immunovia AB (publ)

    Immunovia AB (publ) is not Shariah Compliant because it fails the financial ratios.

    BOUL – Boule Diagnostics AB

    Boule Diagnostics AB is not Shariah Compliant because it fails the financial ratios.

    MEABb – Malmbergs Elektriska AB (publ)

    Malmbergs Elektriska AB (publ) is Shariah Compliant. It passes 3/5 Shariah standards we screen against.

    ISOFOL – Isofol Medical AB (publ)

    Isofol Medical AB (publ) is Shariah Compliant. It passes 2/5 Shariah standards we screen against.

    NETEL – Netel Holding AB (publ)

    Netel Holding AB (publ) is not Shariah Compliant because it fails the financial ratios.

    Load More

    Post Types

    • Stock (28,765)
    • Page (25)
    • Post (1)

    Categories

    • Uncategorized (1)

    Tags

    • NASDAQ (3,605)
    • Bombay Stock Exchange (2,845)
    • National Stock Exchange of India (2,818)
    • NYSE (1,969)
    • Australian Stock Exchange Ltd (1,683)

    Year

    • 2025 (28,791)
    © 2026 - RaqabaIQ
    • Disclaimer
    • Terms and Conditions
    • Privacy Policy
    • Contact

    RaqabaIQ delivers intelligent, transparent, and auditable Shariah compliance solutions—built for modern finance.